Clinical Trial Update: Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the biological effects of adding zoledronic acid to pre-operative chemotherapy in breast cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED